Risk factors for death among patients in French Guiana: 1996-2005

HIV Medicine

Volumn 8, Issue 7, 2007, Pages 472-474

  Nacher, M ^a,b,d   Huber, F ^c   El Guedj, M ^b   Vaz, T ^b   Magnien, C ^b   Djossou, F ^d   Randrianjohany, A ^e   Alvarez, F ^f   Couppie P ^c  

^a Centre d'Information et de Soins de l'Immunodéficience Humaine CISIH de Guyane   (French Guiana)

^b Hôpital de Jour Adultes   (French Guiana)

^c Service de Dermatologie   (French Guiana)

^d CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^e Centre Hospitalier Frank Joly   (French Guiana)

^f Centre Médico Chirurgical de Kourou   (French Guiana)

Author keywords

Addictions; Death; French Guiana; Gender; HIV; Migrants; Risk factors

Indexed keywords

CD4 ANTIGEN;

ADDICTION; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; COVARIANCE; FEMALE; FRENCH GUIANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX RATIO;

ADULT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CAUSE OF DEATH; DISEASE TRANSMISSION; FEMALE; FOLLOW-UP STUDIES; FRENCH GUIANA; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; TRANSIENTS AND MIGRANTS;

EID: 34548336424     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2007.00492.x     Document Type: Article

References (11)

1. Nacher M, El Guedj M, Vaz T et al. Risk factors for late HIV diagnosis in French Guiana. AIDS 2005; 19: 727-729.
2. Nacher M, El Guedj M, Vaz T et al. Risk factors for follow-up interruption of HIV patients in French Guiana. Am J Trop Med Hyg 2006; 74: 915-917.
3. Webber MP, Schoenbaum EE, Gourevitch MN, Buono D, Klein RS. A prospective study of HIV disease progression in female and male drug users. AIDS 1999; 13: 257-262.
4. Crisp BR, Williams M, Timpson S, Ross MW. Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS Behav 2004; 8: 199-206.
5. Thorpe LE, Frederick M, Pitt J et al. Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women. J Acquir Immune Defic Syndr 2004; 37: 1423-1430.
6. Lloyd-Smith E, Brodkin E, Wood E et al. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 2006; 20: 445-450.
7. Nash D, Katyal M, Shah S. Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001. J Urban Health 2005; 82: 584-600.
8. Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr 2002; 30: 111-118.
9. Cardoso MN, Caiaffa WT, Mingoti SA. Projeto AjUDE-Brasil II. AIDS incidence and mortality in injecting drug users: The AjUDE-Brasil II Project. Cad Saude Publica 2006; 22: 827-837.
10. Delfraissy JF. Prise en Charge des Personnes Infectées par le VIH. Paris, France: Médecine-Science Flammarion, 2004.
11. Booth RE, Kwiatkowski CF, Weissman G. Health-related service utilization and HIV risk behaviors among HIV infected injection drug users and crack smokers. Drug Alcohol Depend 1999; 55: 69-78.